United States-based Pfizer is opening a new manufacturing facility in Andover, Massachusetts, it was reported yesterday.
The facility covers a 175,000 square-foot area. It accommodates commercial manufacturing and product development functions for the development and production of complex biologics and vaccines. The site will offer 75 new jobs for the Andover area economy, adding to the around 2,000 staff currently based in Massachusetts.
The newly opened Andover Clinical Manufacturing Facility will expand the capacity for Pfizer's BioTherapeutics Pharmaceutical Sciences organization to manufacture clinical supplies. The company's ACMF investment is more than USD200m and includes five independent manufacturing suites, with more than 50 projects currently in development.
Virbac expands presence in Japan with Sasaeah acquisition
Pfizer reveals strong efficacy data for ABRYSVO in older adults against RSV
US CDC advisory committee backs Valneva's chikungunya vaccine
Takeda and Biological E. Limited join forces to combat global dengue threat
SK bioscience 'SKYTyphoid' receives WHO prequalification certification
ImmunityBio advances cancer vaccine trial for Lynch syndrome participants
AstraZeneca boosts vaccine portfolio with acquisition of Icosavax
Ultimovacs gains EMA Orphan Drug status for UV1 cancer vaccine in mesothelioma